All Stories

  1. Identification and evaluation of glutathione conjugate gamma-l-glutamyl-l-cysteine for improved drug delivery to the brain
  2. Design and development of bioinspired calcium phosphate nanoparticles of MTX: pharmacodynamic and pharmacokinetic evaluation
  3. Formulation development and evaluation of nifedipine as pylorospasm inhibitor
  4. Thymoquinone Therapeutic Potential Against Triple-negative Breast Cancer
  5. Cellulose nanofiber aerogel as a promising biomaterial for customized oral drug delivery
  6. A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives
  7. Formulation Design of Micronized Silver Sulfadiazine Containing Aloe vera Gel for Wound Healing
  8. Nanotechnology-based inhalation treatments for lung cancer: state of the art
  9. Role of Graphene Nano-Composites in Cancer Therapy: Theranostic Applications, Metabolic Fate and Toxicity Issues
  10. Curcumin-loaded colloidal carrier system: formulation optimization, mechanistic insight, ex vivo and in vivo evaluation
  11. Three Ply-Walled Microcapsules for Enhanced Pharmacokinetics of Poorly Absorbed Risedronate Sodium: Novel Stratagem Toward Osteoporosis
  12. Nanomedicine-based drug targeting for psoriasis: potentials and emerging trends in nanoscale pharmacotherapy
  13. Transformation of Curcumin from Food Additive to Multifunctional Medicine: Nanotechnology Bridging the Gap
  14. Role of Nanomedicines in Delivery of Anti-Acetylcholinesterase Compounds to the Brain in Alzheimer’s Disease
  15. Elastic liposome-based gel for topical delivery of 5-fluorouracil:in vitroandin vivoinvestigation
  16. Dorzolamide-loaded PLGA/vitamin E TPGS nanoparticles for glaucoma therapy: Pharmacoscintigraphy study and evaluation of extended ocular hypotensive effect in rabbits
  17. Nanotechnology to Combat Multidrug Resistance in Cancer
  18. PNIPAM nanoparticles for targeted and enhanced nose-to-brain delivery of curcuminoids: UPLC/ESI-Q-ToF-MS/MS-based pharmacokinetics and pharmacodynamic evaluation in cerebral ischemia model
  19. Nanomedicine Based Drug Targeting in Alzheimer’s Disease: High Impact of Small Carter
  20. Nanotechnology for single shot vaccine
  21. Synthesis and in vitro localization study of curcumin-loaded SPIONs in a micro capillary for simulating a targeted drug delivery system
  22. Theranostic Metallic Nanomedicine in Oncology: New Insights and Concerns
  23. Development of Poly Lactide-Co-Glycolide Nanodispersions for Enhanced Ocular Delivery of Moxifloxacin
  24. Nanoethosomes mediated transdermal delivery of vinpocetine for management of Alzheimer’s disease
  25. Mucoadhesive elementary osmotic pump tablets of trimetazidine for controlled drug delivery and reduced variability in oral bioavailability
  26. Enhanced stability and permeation potential of nanoemulsion containing sefsol-218 oil for topical delivery of amphotericin B
  27. Fabrication of nanoadjuvant with poly-e-caprolactone (PCL) for developing a single-shot vaccine providing prolonged immunity
  28. Evaluation of a classical unani pharmacopeial formulation safoof-e-muhazzil in hyperlipidemia: A randomized, standard controlled clinical study
  29. Prospective Corollary of Ophthalmic Nanomedicine
  30. Perceptive solutions to anti-filarial chemotherapy of lymphatic filariasis from the plethora of nanomedical sciences
  31. In vivo lung deposition and sub-acute inhalation toxicity studies of nano-sized alendronate sodium as an antidote for inhaled toxic substances in Sprague Dawley rats
  32. Pulmonary delivery of nanosized alendronate for decorporation of inhaled heavy metals: formulation development, characterization and gamma scintigraphic evaluation
  33. Improved antifilarial activity of ivermectin in chitosan–alginate nanoparticles against human lymphatic filarial parasite, Brugia malayi
  34. Chromatographic separation of piracetam and its metabolite in a mixture of microsomal preparations, followed by an MS/MS analysis
  35. A comparative study of PNIPAM nanoparticles of curcumin, demethoxycurcumin, and bisdemethoxycurcumin and their effects on oxidative stress markers in experimental stroke
  36. Quantification of curcumin, demethoxycurcumin, and bisdemethoxycurcumin in rodent brain by UHPLC/ESI-Q-TOF-MS/MS after intra-nasal administration of curcuminoids loaded PNIPAM nanoparticles
  37. Collagen loaded nano-sized surfactant based dispersion for topical application: formulation development, characterization and safety study
  38. Nanomedicines as Cancer Therapeutics: Current Status
  39. Omega – 3 Fatty Acids as Pharmacotherapeutics in Psoriasis: Current Status and Scope of Nanomedicine in its Effective Delivery
  40. Nanocarrier-based topical drug delivery for an antifungal drug
  41. Nanopotentiation of Propolis for Revocation of Enzyme Imbalance in UVB Induced Cutaneous Toxicity in Murine Model: a Preliminary Study for Chemoprotection of Skin Cancer
  42. Application of Decoy Oligonucleotides as Novel Therapeutic Strategy: A Contemporary Overview
  43. Nanopharmaceuticals to target antifilarials: a comprehensive review
  44. Development, characterisation and pharmacoscintigraphic evaluation of nano-fluticasone propionate dry powder inhalation as potential antidote against inhaled toxic gases
  45. Thymoquinone: Major Molecular Targets, Prominent Pharmacological Actions and Drug Delivery Concerns
  46. Nanocarrier based formulation of Thymoquinone improves oral delivery: Stability assessment, in vitro and in vivo studies
  47. Application of Decoy Oligonucleotides as Novel Therapeutic Strategy: A Contemporary Overview
  48. Ocular pharmacoscintigraphic and aqueous humoral drug availability of ganciclovir-loaded mucoadhesive nanoparticles in rabbits
  49. Anticonvulsant, Anxiolytic and Neurotoxicity Profile of Aqarqarha (<i>Anacyclus pyrethrum</i>) DC (Compositae) Root Ethanolic Extract
  50. Efficacy of a classical antiobesity Unani pharmacopial formulation (Safoof-e-Muhazzil) in systolic and diastolic blood pressure: A randomized, open-labeled, controlled clinical study
  51. Aerodynamics and Deposition Effects of Inhaled Submicron Drug Aerosol in Airway Diseases
  52. Microemulsion as a tool for the transdermal delivery of ondansetron for the treatment of chemotherapy induced nausea and vomiting
  53. Nanometric gold in cancer nanotechnology: current status and future prospect
  54. Application of a liquid chromatography-electrospray mass spectrometry (LC/MS) method to the biodistribution and excretion studies of novel 5′-chloro-2, 3-didehydroindolo (2′, 3′: 2, 3) betulinic acid (DRF-4012) in tumour-bearing mice
  55. Assam Bora Rice Starch Based Biocompatible Mucoadhesive Microsphere for Targeted Delivery of 5-Fluorouracil in Colorectal Cancer
  56. Development and evaluation of thymoquinone-encapsulated chitosan nanoparticles for nose-to-brain targeting: a pharmacoscintigraphic study
  57. Aerodynamics and Deposition Effects of Inhaled Submicron Drug Aerosol in Airway Diseases
  58. Aerodynamics and Deposition Effects of Inhaled Submicron Drug Aerosol in Airway Diseases
  59. Colorectal cancer targeted Irinotecan-Assam Bora rice starch based microspheres: a mechanistic, pharmacokinetic and biochemical investigation
  60. Novel Approach for the Treatment of Cancer: Theranostic Nanomedicine
  61. Stabilized terbutaline submicron drug aerosol for deep lungs deposition: Drug assay, pulmonokinetics and biodistribution by UHPLC/ESI-q-TOF-MS method
  62. Gold nanoparticles in theranostic oncology: current state-of-the-art
  63. Efficacy of Mycobacterium indicus pranii Immunotherapy as an Adjunct to Chemotherapy for Tuberculosis and Underlying Immune Responses in the Lung
  64. Classical to Current Approach for Treatment of Psoriasis: A Review
  65. Role of CD44 in tumour progression and strategies for targeting
  66. Compactibility and compressibility studies of Assam Bora rice starch
  67. Contemporary Overview on Clinical Trials and Future Prospects of Hepato-protective Herbal Medicines
  68. Therapeutic stratagems for vascular degenerative disorders of the posterior eye
  69. Enhanced antimalarial activity of lumefantrine nanopowder prepared by wet-milling DYNO MILL technique
  70. Lipidic Nanocarrier for Oral Bioavailability Enhancement of an Anticancer Agent: Formulation Design and Evaluation
  71. Tableting Properties of Assam Bora Rice Starch
  72. Tableting Properties of Assam Bora Rice Starch
  73. Development and Validation of UHPLC/ESI-Q-TOF-MS Method for Terbutaline Estimations in Experimental Rodents: Stability Effects and Plasma Pharmacokinetics
  74. Dual approach utilizing self microemulsifying technique and novel P-gp inhibitor for effective delivery of taxanes
  75. Advancement in multifunctional nanoparticles for the effective treatment of cancer
  76. Insight into the Biomarkers as the Novel Anti-Psoriatic Drug Discovery Tool: A Contemporary Viewpoint
  77. Inhalation of alendronate nanoparticles as dry powder inhaler for the treatment of osteoporosis
  78. In vitroandin vivoevaluation ofAssam Borarice starch-based bioadhesive microsphere as a drug carrier for colon targeting
  79. Feasibility of Assam Bora Rice Starch as a Compression Coat of 5-Fluorouracil Core Tablet for Colorectal Cancer
  80. Mechanophysical-Chemotherapy Combinations: A Dual Approach to Combat Cancer
  81. Oil based nanocarrier system for transdermal delivery of ropinirole: A mechanistic, pharmacokinetic and biochemical investigation
  82. Enhanced bioavailability of nano-sized chitosan–atorvastatin conjugate after oral administration to rats
  83. Bioanalysis Young Investigator: Niyaz Ahmad
  84. Edetate calcium disodium nanoparticle dry powder inhalation: A novel approach against heavy metal decorporation
  85. Development of Polysaccharide based Colon Targeted Drug Delivery System: Design and Evaluation of Assam Bora rice Starch based Matrix Tablet
  87. Aqueous Humor Pharmacokinetics of Dorzolamide Loaded PLGAChitosan Nanoparticles by Ultra Performance Liquid Chromatography
  88. Formulation development and optimization of alpha ketoglutarate nanoparticles for cyanide poisoning
  89. A validated HPTLC method for determination of terbutaline sulfate in biological samples: Application to pharmacokinetic study
  90. Cancer Targeted Metallic Nanoparticle: Targeting Overview, Recent Advancement and Toxicity Concern
  91. Development of nano alpha-ketoglutarate nebulization formulation and its pharmacokinetic and safety evaluation in healthy human volunteers for cyanide poisoning
  92. Aqueous Synthesis and Concentration-Dependent Dermal Toxicity of TiO2 Nanoparticles in Wistar Rats
  93. The emerging role of P-glycoprotein inhibitors in drug delivery: a patent review
  94. Microscopic and spectroscopic evaluation of novel PLGA–chitosan Nanoplexes as an ocular delivery system
  95. LC–UV Detection of 5′-Chloro-2,3-didehydroindolo[2′,3′:2,3]betulinic Acid in Rat Plasma and Its Application to a Pharmacokinetic Study
  96. Antiepileptic Intranasal Amiloride Loaded Mucoadhesive Nanoemulsion: Development and Safety Assessment
  97. Assessment of Ocular Pharmacokinetics and Safety of Ganciclovir Loaded Nanoformulations
  98. Concentration Dependent Toxicity of ∼20 nm Anatase Titanium Dioxide Nanoparticles—An In Vivo Study on Wistar Rats
  99. Mechanistic study of hydrolytic erosion and drug release behaviour of PLGA nanoparticles: Influence of chitosan
  100. Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress
  101. Insights into the novel three ‘D's of epilepsy treatment: drugs, delivery systems and devices
  102. Stability-indicating ultra-performance liquid chromatography method for the estimation of thymoquinone and its application in biopharmaceutical studies
  103. Metallic nanoparticles: technology overview & drug delivery applications in oncology
  104. Determination of Alendronate Sodium by Box-Behnken Statistical Design
  106. Ultra high-pressure liquid chromatographic assay of moxifloxacin in rabbit aqueous humor after topical instillation of moxifloxacin nanoparticles
  107. Bioanalytical approaches, bioavailability assessment, and bioequivalence study for waiver drugs: In vivo and in vitro perspective
  108. Critical evaluation of permeation enhancers for oral mucosal drug delivery
  109. 3-Acetyl-11-keto-β-boswellic acid loaded-polymeric nanomicelles for topical anti-inflammatory and anti-arthritic activity
  110. Stability Indicating HPTLC Method for Determination of Terbutaline Sulfate in Bulk and from Submicronized Dry Powder Inhalers
  111. Effect of Paeonia emodi wall root extract on pentylenetetrazole-induced kindling, cognition and oxidative stress in mice
  112. Quantitative analysis of safranal in saffron extract and nanoparticle formulation by a validated high-performance thin-layer chromatographic method†
  113. Nanocarrier for the Transdermal Delivery of an Antiparkinsonian Drug
  114. Critical evaluation of permeation enhancers for oral mucosal drug delivery
  115. Microemulsions as a Surrogate Carrier for Dermal Drug Delivery
  116. Components Screening and Influence of Surfactant and Cosurfactant on Nanoemulsion Formation
  117. Development and clinical trial of nano-atropine sulfate dry powder inhaler as a novel organophosphorous poisoning antidote
  118. Nano-salbutamol dry powder inhalation: A new approach for treating broncho-constrictive conditions
  119. Nanoemulsion Components Screening and Selection: a Technical Note
  120. An HPTLC Method for the Determination of Minocycline in Human Plasma, Saliva, and Gingival Fluid after Single Step Liquid Extraction
  121. Retraction: An HPTLC Method for the Determination of Minocycline in Human Plasma, Saliva, and Gingival Fluid after Single Step Liquid Extraction
  122. CNS Drug Delivery Systems: Novel Approaches
  123. Microemulsions: A Novel Approach to Enhanced Drug Delivery
  124. Emerging Role of Microemulsions in Cosmetics
  125. Recent approaches for the treatment of periodontitis
  126. Investigation of Nanoemulsion System for Transdermal Delivery of Domperidone: Ex-vivo and in vivo Studies
  127. Potential prospects of chitosan derivative trimethyl chitosan chloride (TMC) as a polymeric absorption enhancer: synthesis, characterization and applications
  128. Buccoadhesive Drug Delivery Systems - Extensive Review on Recent Patents
  129. Nonionic Surfactant Vesicles as a Carrier for Transdermal Delivery of Frusemide
  130. Development and Characterization of Liposome‐Based Formulation of Amiloride Hydrochloride
  131. Feasibility of Proniosomes-Based Transdermal Delivery of Frusemide: Formulation Optimization and Pharmacotechnical Evaluation
  132. Solid Self-Nanoemulsifying Delivery Systems as a Platform Technology for Formulation of Poorly Soluble Drugs
  133. Dental Therapeutic Systems
  134. Development and characterization of chitosan succinate microspheres for the improved oral bioavailability of insulin
  135. Simple, sensitive, selective and validated spectrophotometric methods for the estimation of a biomarker trigonelline from polyherbal gels
  136. Development and evaluation of acid-buffering bioadhesive vaginal tablet for mixed vaginal infections
  137. Development and in-vivo evaluation of insulin-loaded chitosan phthalate microspheres for oral delivery
  138. Validated spectrophotometric methods for the estimation of moxifloxacin in bulk and pharmaceutical formulations
  139. Validated stability-indicating densitometric thin-layer chromatography: Application to stress degradation studies of minocycline
  140. Optimisation of polyherbal gels for vaginal drug delivery by Box-Behnken statistical design
  141. Development and bioavailability assessment of ramipril nanoemulsion formulation
  142. Design and Development of Oral Oil in Water Ramipril Nanoemulsion Formulation: In Vitro and In Vivo Assessment
  143. Transdermal therapeutic system of carvedilol: Effect of hydrophilic and hydrophobic matrix on in vitro and in vivo characteristics
  144. Quantitative Determination and Stress Degradation Studies on a Biomarker Trigonelline by a Validated Stability‐Indicating HPTLC Method
  145. Folate coupled poly(ethyleneglycol) conjugates of anionic poly(amidoamine) dendrimer for inflammatory tissue specific drug delivery
  146. Application of a validated stability-indicating densitometric thin-layer chromatographic method to stress degradation studies on moxifloxacin
  147. The development of folate-PAMAM dendrimer conjugates for targeted delivery of anti-arthritic drugs and their pharmacokinetics and biodistribution in arthritic rats
  148. Multiple Emulsions: An Overview
  149. Validated high-performance thin-layer chromatography method for determination of trigonelline in herbal extract and pharmaceutical dosage form
  150. Advances and potential applications of chitosan derivatives as mucoadhesive biomaterials in modern drug delivery
  151. Stability indicating high-performance thin-layer chromatographic determination of gatifloxacin as bulk drug and from polymeric nanoparticles
  152. Amiloride protects against pentylenetetrazole-induced kindling in mice
  153. Evidence of the antiepileptic potential of amiloride with neuropharmacological benefits in rodent models of epilepsy and behavior